214 related articles for article (PubMed ID: 1634225)
1. Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene.
Mottes M; Sangalli A; Valli M; Gomez Lira M; Tenni R; Buttitta P; Pignatti PF; Cetta G
Hum Genet; 1992 Jul; 89(5):480-4. PubMed ID: 1634225
[TBL] [Abstract][Full Text] [Related]
2. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1).
Constantinou CD; Pack M; Young SB; Prockop DJ
Am J Hum Genet; 1990 Oct; 47(4):670-9. PubMed ID: 2220807
[TBL] [Abstract][Full Text] [Related]
5. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
[TBL] [Abstract][Full Text] [Related]
6. A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.
Bonaventure J; Cohen-Solal L; Lasselin C; Maroteaux P
Hum Genet; 1992 Aug; 89(6):640-6. PubMed ID: 1511982
[TBL] [Abstract][Full Text] [Related]
7. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622
[TBL] [Abstract][Full Text] [Related]
8. Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells. Application to the characterization of a glycine 997 to serine substitution in alpha 1(II) collagen chains of a patient with spondyloepiphyseal dysplasia.
Chan D; Cole WG
J Biol Chem; 1991 Jul; 266(19):12487-94. PubMed ID: 1905723
[TBL] [Abstract][Full Text] [Related]
9. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
[TBL] [Abstract][Full Text] [Related]
10. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
[TBL] [Abstract][Full Text] [Related]
11. Moderately severe osteogenesis imperfecta associated with substitutions of serine for glycine in the alpha 1(I) chain of type I collagen.
Marini JC; Lewis MB; Chen K
Am J Med Genet; 1993 Jan; 45(2):241-5. PubMed ID: 8456809
[TBL] [Abstract][Full Text] [Related]
12. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
[TBL] [Abstract][Full Text] [Related]
13. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW
J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847
[TBL] [Abstract][Full Text] [Related]
14. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
Bateman JF; Hannagan M; Chan D; Cole WG
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
[TBL] [Abstract][Full Text] [Related]
16. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
[TBL] [Abstract][Full Text] [Related]
17. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
Wallis GA; Starman BJ; Zinn AB; Byers PH
Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
[TBL] [Abstract][Full Text] [Related]
19. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):131-5. PubMed ID: 1445258
[TBL] [Abstract][Full Text] [Related]
20. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
Lamande SR; Dahl HH; Cole WG; Bateman JF
J Biol Chem; 1989 Sep; 264(27):15809-12. PubMed ID: 2777764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
